Ostroff Stresses Importance Of 'Cures' Hiring Language, Sees Science Board Report As Leverage

Acting FDA Commissioner Stephen Ostroff said he hopes a new FDA Science Board report that warns new agency hiring authority and funding is needed to spur medical product innovation will help convince lawmakers to include adequate funding for FDA in the House 21st Century Cures bill and the Senate's upcoming Innovation for Healthier Americans legislation. If the agency doesn't receive enough funding for the activities called for in the Cures legislation, he recently told reporters, FDA's progress in a number...